A new drug has been hailed as a “turning point in the fight against Alzheimer’s” after it was found to slow the progression of the disease. Donanemab was found to slow “clinical decline” by up to 35 per cent, meaning that people with the disease could still go about performing day-to-day tasks including shopping, housekeeping,…

Read more →